Thymic malignanciesSMIT, E. F.Annals of oncology. 2008, Vol 19, issn 0923-7534, vii309-vii312, SUP7Article

High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases—One with a remarkable thoracic response as wellKUIPER, J. L; SMIT, E. F.Lung cancer. 2013, Vol 80, Num 1, pp 102-105, issn 0169-5002, 4 p.Article

A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapyBIESMA, B; SMIT, E. F; POSTMUS, P. E et al.Lung cancer. 1999, Vol 24, Num 2, pp 115-121, issn 0169-5002Article

Chemotherapy for brain metastases of lung cancer : A reviewPOSTMUS, P. E; SMIT, E. F.Annals of oncology. 1999, Vol 10, Num 7, pp 753-759, issn 0923-7534Article

Nouveautés présentées à l'ASCO 2002 concernant les cancers bronchiques à petites cellules = New chimiotherapy at ASCO 2002 in bronchopulmonary small cellular carcinomaSMIT, E.-F.Revue de pneumologie clinique (Paris). 2002, Vol 58, Num 5, pp 3S11-3S14, issn 0761-8417, CAH2Conference Paper

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced diseaseBESSE, B; ADJEI, A; FELIP, E et al.Annals of oncology. 2014, Vol 25, Num 8, pp 1475-1484, issn 0923-7534, 10 p.Article

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatmentWACHTERS, F. M; GROEN, H. J. M; BIESMA, B et al.British journal of cancer. 2005, Vol 92, Num 1, pp 15-20, issn 0007-0920, 6 p.Article

A patient with fatigue and subfebrile temperatureHERDER, G. J. M; SMIT, E. F; BORGSTEIN, P. J et al.The European respiratory journal. 2000, Vol 16, Num 1, pp 184-186, issn 0903-1936Article

A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patientsGIACCONE, G; SMIT, E. F; VAN MEERBEECK, J. P et al.Annals of oncology. 2000, Vol 11, Num 1, pp 109-112, issn 0923-7534Article

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer : A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)VAN ZANDWIJK, M; SMIT, E. F; GIACCONE, G et al.Journal of clinical oncology. 2000, Vol 18, Num 14, pp 2658-2664, issn 0732-183XArticle

A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimensMEERSMA, G. J; BAKKER, M; GROEN, H. J. M et al.Anticancer research. 1999, Vol 19, Num 2A, pp 1309-1315, issn 0250-7005Article

Quantitation of DNA topoisomerase IIα messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assayWITHOFF, S; SMIT, E. F; MEERSMA, G. J et al.Laboratory investigation. 1994, Vol 71, Num 1, pp 61-66, issn 0023-6837Article

Results of whole brain radiotherapy for brain metastases of small cell lung cancerHAGEDORN, H. E; HAAXMA-REICHE, H; CANRINUS, A. A et al.Lung cancer. 1993, Vol 8, Num 5-6, pp 293-300, issn 0169-5002Conference Paper

Limitations of the fast green assay for chemosensitivity testing in human lung cancerSMIT, E. F; DE VRIES, E. G. E; MEIJER, C et al.Chest. 1991, Vol 100, Num 5, pp 1358-1363, issn 0012-3692Article

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancerSMIT, E. F; BERENDSEN, H. H; DE VRIES, E. G. E et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 3, pp 202-204, issn 0344-5704Article

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trialEDIEBAH, D. E; COENS, C; WEIS, J et al.British journal of cancer. 2014, Vol 110, Num 10, pp 2427-2433, issn 0007-0920, 7 p.Article

Trimodality therapy for stage IIIA non-small cell lung cancer: Benchmarking multi-disciplinary team decision-making and functionDICKHOFF, C; HARTEMINK, K. J; VAN DE VEN, P. M et al.Lung cancer. 2014, Vol 85, Num 2, pp 218-223, issn 0169-5002, 6 p.Article

SUV_max during 18FDG-PET scanning in small cell lung cancer: Similar information as in non-small cell lung cancer?DER LEEST, C. Van; SMIT, E. F; BAAS, J et al.Lung cancer. 2012, Vol 76, Num 1, pp 67-71, issn 0169-5002, 5 p.Article

Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studiesSURMONT, V; SMIT, E. F; SENAN, S et al.Lung cancer. 2010, Vol 69, Num 3, pp 302-306, issn 0169-5002, 5 p.Article

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)PHERNAMBUCQ, E. C. J; BIESMA, B; SMIT, E. F et al.British journal of cancer. 2006, Vol 95, Num 4, pp 470-474, issn 0007-0920, 5 p.Article

Failure patterns of combined modality treatment in lung cancer: The impact of stagingHOEKSTRA, C. J; RIJNA, H; SMIT, E. F et al.Netherlands journal of medicine. 2002, Vol 60, Num 1, pp 17-21, issn 0300-2977Article

DNA topoisomerase IIα and -β expression in human ovarian cancerWITHOFF, S; VAN DER ZEE, A. G. J; DE JONG, S et al.British journal of cancer. 1999, Vol 79, Num 5-6, pp 748-753, issn 0007-0920Article

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancerSMIT, E. F; FOKKEMA, E; BIESMA, B et al.British journal of cancer. 1998, Vol 77, Num 2, pp 347-351, issn 0007-0920Article

Effects of gemcitabine on renal function in patients with non-small cell lung cancerGIETEMA, J. A; GROEN, H. J. M; MEIJER, S et al.European journal of cancer (1990). 1998, Vol 34, Num 1, pp 199-202, issn 0959-8049Article

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IVBAKKER, M; GROEN, H. J. M; SMIT, E. F et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1547-1550, issn 0007-0920Article